| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.631 | 0.003 | 0.631 | Porphobilinogen synthase inhibitor | 0.421 0.004 DBMET00887 | ||
| 0.557 | 0.015 | 0.557 | Histamine release inhibitor | 0.548 0.017 DBMET00887 | ||
| 0.543 | 0.03 | 0.543 | Antibacterial | 0.534 0.032 DBMET00887 | ||
| 0.519 | 0.012 | 0.534 | DNA synthesis inhibitor | 0.534 0.011 DBMET00887 | DBMET00887 | |
| 0.51 | 0.023 | 0.51 | GABA C receptor rho-3 antagonist | 0.386 0.068 DBMET00887 | ||
| 0.491 | 0.035 | 0.491 | 5 Hydroxytryptamine release inhibitor | 0.341 0.123 DBMET00887 | ||
| 0.428 | 0.009 | 0.428 | Topoisomerase II inhibitor | 0.373 0.012 DBMET00887 | ||
| 0.46 | 0.045 | 0.602 | Calcium channel L-type activator | 0.602 0.005 DBMET00887 | DBMET00887 | |
| 0.445 | 0.065 | 0.445 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.373 0.126 DBMET00887 | ||
| 0.335 | 0.004 | 0.343 | Autotaxin inhibitor | 0.343 0.004 DBMET00887 | DBMET00887 | |
| 0.343 | 0.027 | 0.4 | Cyclic AMP phosphodiesterase inhibitor | 0.4 0.016 DBMET00887 | DBMET00887 | |
| 0.349 | 0.034 | 0.349 | Pyruvate kinase inhibitor | 0.178 0.095 DBMET00887 | ||
| 0.318 | 0.006 | 0.318 | Ferrochelatase inhibitor | 0.174 0.029 DBMET00887 | ||
| 0.382 | 0.123 | 0.382 | DNA directed DNA polymerase inhibitor | 0.33 0.147 DBMET00887 | ||
| 0.259 | 0.009 | 0.291 | Mediator release inhibitor | 0.291 0.008 DBMET00887 | DBMET00887 | |
| 0.239 | 0.004 | 0.239 | DNA gyrase inhibitor | 0.224 0.004 DBMET00887 | ||
| 0.208 | 0.016 | 0.208 | GABA receptor agonist | 0.207 0.016 DBMET00887 | ||
| 0.244 | 0.053 | 0.248 | RNA-directed DNA polymerase inhibitor | 0.248 0.051 DBMET00887 | DBMET00887 | |
| 0.212 | 0.029 | 0.212 | Hexokinase inhibitor | 0.191 0.041 DBMET00887 | ||
| 0.184 | 0.013 | 0.184 | Creatine kinase inhibitor | 0.156 0.021 DBMET00887 | ||
| 0.252 | 0.081 | 0.252 | Aldehyde oxidase inhibitor | 0.176 0.119 DBMET00887 | ||
| 0.21 | 0.043 | 0.21 | Cytidine deaminase inhibitor | 0.142 0.082 DBMET00887 | ||
| 0.263 | 0.096 | 0.263 | Streptokinase A inhibitor | |||
| 0.197 | 0.03 | 0.197 | GABA C receptor rho-2 antagonist | 0.155 0.067 DBMET00887 | ||
| 0.205 | 0.045 | 0.205 | Succinate dehydrogenase inhibitor | 0.191 0.057 DBMET00887 | ||
| 0.217 | 0.057 | 0.217 | I kappa B kinase epsilon inhibitor | 0.187 0.083 DBMET00887 | ||
| 0.243 | 0.088 | 0.243 | Gastrin inhibitor | 0.219 0.12 DBMET00887 | ||
| 0.167 | 0.013 | 0.177 | GABA A receptor agonist | 0.177 0.012 DBMET00887 | DBMET00887 | |
| 0.247 | 0.099 | 0.247 | Insulysin inhibitor | |||
| 0.168 | 0.021 | 0.168 | Adenylate kinase inhibitor | 0.161 0.023 DBMET00887 | ||
| 0.154 | 0.01 | 0.154 | Alcohol oxidase inhibitor | 0.128 0.013 DBMET00887 | ||
| 0.165 | 0.022 | 0.165 | Heat shock protein 70 antagonist | 0.14 0.073 DBMET00887 | ||
| 0.18 | 0.041 | 0.238 | Phosphodiesterase inhibitor | 0.238 0.025 DBMET00887 | DBMET00887 | |
| 0.146 | 0.009 | 0.146 | HIV-1 integrase inhibitor | 0.133 0.011 DBMET00887 | ||
| 0.243 | 0.107 | 0.267 | Hypoxia-inducible factor 1 alpha inhibitor | 0.267 0.086 DBMET00887 | DBMET00887 | |
| 0.145 | 0.012 | 0.187 | Phosphodiesterase 5A inhibitor | 0.187 0.007 DBMET00887 | DBMET00887 | |
| 0.144 | 0.012 | 0.185 | Phosphodiesterase V inhibitor | 0.185 0.007 DBMET00887 | DBMET00887 | |
| 0.139 | 0.008 | 0.139 | Phosphodiesterase VI inhibitor | 0.128 0.01 DBMET00887 | ||
| 0.172 | 0.046 | 0.182 | Cell wall synthesis inhibitor | 0.182 0.039 DBMET00887 | DBMET00887 | |
| 0.144 | 0.019 | 0.179 | NADH dehydrogenase inhibitor | 0.179 0.013 DBMET00887 | DBMET00887 | |
| 0.152 | 0.028 | 0.214 | UDP-glucose 4-epimerase inhibitor | 0.214 0.016 DBMET00887 | DBMET00887 | |
| 0.243 | 0.13 | 0.288 | Cholesterol antagonist | 0.288 0.099 DBMET00887 | DBMET00887 | |
| 0.138 | 0.027 | 0.138 | GABA C receptor rho-1 antagonist | 0.104 0.057 DBMET00887 | ||
| 0.147 | 0.042 | 0.147 | Cystathionine beta-synthase inhibitor | 0.109 0.068 DBMET00887 | ||
| 0.117 | 0.014 | 0.117 | Biliverdin reductase inhibitor | 0.104 0.017 DBMET00887 | ||
| 0.13 | 0.032 | 0.13 | Uric acid excretion stimulant | 0.116 0.041 DBMET00887 | ||
| 0.101 | 0.005 | 0.101 | DNA gyrase subunit B inhibitor | 0.085 0.005 DBMET00887 | ||
| 0.156 | 0.061 | 0.156 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.13 0.118 DBMET00887 | ||
| 0.103 | 0.009 | 0.103 | Topoisomerase II beta inhibitor | 0.052 0.029 DBMET00887 | ||
| 0.118 | 0.027 | 0.12 | Phosphodiesterase 6D inhibitor | 0.12 0.025 DBMET00887 | DBMET00887 | |
| 0.122 | 0.031 | 0.153 | Triose-phosphate isomerase inhibitor | 0.153 0.019 DBMET00887 | DBMET00887 | |
| 0.128 | 0.037 | 0.128 | DOPA decarboxylase inhibitor | 0.111 0.057 DBMET00887 | ||
| 0.122 | 0.033 | 0.122 | Alcohol dehydrogenase inhibitor | 0.109 0.044 DBMET00887 | ||
| 0.111 | 0.025 | 0.111 | HIV-1 reverse transcriptase inhibitor | 0.091 0.035 DBMET00887 | ||
| 0.149 | 0.065 | 0.149 | Mannose-6-phosphate isomerase inhibitor | 0.117 0.106 DBMET00887 | ||
| 0.148 | 0.065 | 0.148 | Sphingosine 1-phosphate receptor 5 antagonist | 0.127 0.106 DBMET00887 | ||
| 0.142 | 0.066 | 0.142 | Ca2+-transporting ATPase inhibitor | 0.136 0.088 DBMET00887 | ||
| 0.08 | 0.005 | 0.08 | DNA gyrase subunit A inhibitor | 0.074 0.006 DBMET00887 | ||
| 0.108 | 0.033 | 0.108 | Interleukin 5 antagonist | 0.096 0.046 DBMET00887 | ||
| 0.183 | 0.111 | 0.183 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.149 | 0.078 | 0.149 | Peroxidase inhibitor | |||
| 0.109 | 0.039 | 0.165 | Phosphodiesterase IV inhibitor | 0.165 0.019 DBMET00887 | DBMET00887 | |
| 0.147 | 0.078 | 0.147 | Insulin secretagoues | |||
| 0.1 | 0.032 | 0.121 | Histidine decarboxylase inhibitor | 0.121 0.025 DBMET00887 | DBMET00887 | |
| 0.253 | 0.186 | 0.253 | MAP kinase kinase 6 inhibitor | |||
| 0.132 | 0.065 | 0.132 | Antibacterial (Helicobacter pylori) | 0.113 0.093 DBMET00887 | ||
| 0.117 | 0.052 | 0.117 | GABA C receptor agonist | 0.09 0.078 DBMET00887 | ||
| 0.137 | 0.075 | 0.137 | Ribosomal protein S6 kinase inhibitor | |||
| 0.095 | 0.034 | 0.095 | Glutamate dehydrogenase inhibitor | 0.087 0.039 DBMET00887 | ||
| 0.093 | 0.034 | 0.093 | Glutamate decarboxylase inhibitor | 0.078 0.046 DBMET00887 | ||
| 0.164 | 0.105 | 0.164 | Psychostimulant | |||
| 0.128 | 0.07 | 0.182 | Alpha-N-acetylglucosaminidase inhibitor | 0.182 0.04 DBMET00887 | DBMET00887 | |
| 0.058 | 0.005 | 0.058 | DNA topoisomerase IV inhibitor | 0.053 0.005 DBMET00887 | ||
| 0.08 | 0.026 | 0.08 | Phosphodiesterase VII inhibitor | 0.065 0.04 DBMET00887 | ||
| 0.227 | 0.175 | 0.236 | Calcium channel activator | 0.236 0.164 DBMET00887 | DBMET00887 | |
| 0.058 | 0.007 | 0.058 | Angiotensin AT1 receptor antagonist | 0.058 0.008 DBMET00887 | ||
| 0.152 | 0.102 | 0.152 | Lipocortins synthesis antagonist | |||
| 0.106 | 0.055 | 0.106 | Xanthine oxidase inhibitor | |||
| 0.142 | 0.095 | 0.142 | Heat shock protein 90 alpha antagonist | |||
| 0.064 | 0.017 | 0.064 | Phosphodiesterase 7A inhibitor | 0.058 0.024 DBMET00887 | ||
| 0.1 | 0.054 | 0.115 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.115 0.042 DBMET00887 | DBMET00887 | |
| 0.076 | 0.03 | 0.076 | Adenosine A1 receptor antagonist | 0.073 0.031 DBMET00887 | ||
| 0.209 | 0.166 | 0.359 | Vasodilator, peripheral | 0.359 0.07 DBMET00887 | DBMET00887 | |
| 0.074 | 0.034 | 0.074 | HIV-1 integrase (Strand Transfer) inhibitor | 0.053 0.047 DBMET00887 | ||
| 0.047 | 0.008 | 0.047 | Angiotensin II receptor antagonist | 0.047 0.009 DBMET00887 | ||
| 0.054 | 0.017 | 0.054 | Urate transporter 1 inhibitor | |||
| 0.053 | 0.016 | 0.053 | Phosphodiesterase 6C inhibitor | 0.049 0.023 DBMET00887 | ||
| 0.061 | 0.024 | 0.068 | Phosphorylase inhibitor | 0.068 0.021 DBMET00887 | DBMET00887 | |
| 0.068 | 0.033 | 0.068 | Xanthine dehydrogenase inhibitor | |||
| 0.19 | 0.155 | 0.19 | MAP kinase kinase 3 inhibitor | |||
| 0.074 | 0.04 | 0.11 | Phosphodiesterase 4B inhibitor | 0.11 0.021 DBMET00887 | DBMET00887 | |
| 0.104 | 0.072 | 0.104 | GABA C receptor antagonist | |||
| 0.063 | 0.031 | 0.07 | Acyl-CoA dehydrogenase inhibitor | 0.07 0.027 DBMET00887 | DBMET00887 | |
| 0.111 | 0.081 | 0.111 | Aldehyde dehydrogenase inhibitor | 0.111 0.081 DBMET00887 | ||
| 0.097 | 0.068 | 0.142 | Bronchodilator | 0.142 0.034 DBMET00887 | DBMET00887 | |
| 0.097 | 0.07 | 0.097 | Gastric antisecretory | |||
| 0.056 | 0.03 | 0.056 | Aconitate hydratase inhibitor | 0.048 0.041 DBMET00887 | ||
| 0.068 | 0.043 | 0.068 | MDM2 inhibitor | |||
| 0.062 | 0.038 | 0.062 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.066 | 0.042 | 0.066 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.069 | 0.05 | 0.069 | Protein kinase C beta inhibitor | |||
| 0.172 | 0.153 | 0.172 | Superoxide dismutase inhibitor | |||
| 0.072 | 0.054 | 0.072 | Phosphodiesterase 4D inhibitor | |||
| 0.091 | 0.073 | 0.091 | Electrolyte absorption antagonist | |||
| 0.045 | 0.028 | 0.045 | Geranyltranstransferase inhibitor | |||
| 0.136 | 0.119 | 0.136 | Tumour necrosis factor antagonist | |||
| 0.045 | 0.028 | 0.045 | Guanylate cyclase stimulant | |||
| 0.055 | 0.038 | 0.055 | Dihydroorotate oxidase inhibitor | |||
| 0.043 | 0.026 | 0.043 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.133 | 0.117 | 0.133 | Dual specificity phosphatase inhibitor | 0.131 0.118 DBMET00887 | ||
| 0.074 | 0.058 | 0.074 | Keratolytic | |||
| 0.154 | 0.139 | 0.158 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.158 0.131 DBMET00887 | DBMET00887 | |
| 0.081 | 0.066 | 0.081 | Histamine N-methyltransferase inhibitor | |||
| 0.036 | 0.023 | 0.036 | Retinoid X alpha receptor agonist | |||
| 0.127 | 0.116 | 0.127 | Arachidonic acid antagonist | |||
| 0.028 | 0.019 | 0.028 | DNA polymerase III inhibitor | |||
| 0.121 | 0.112 | 0.133 | MAP3K9 inhibitor | 0.133 0.088 DBMET00887 | DBMET00887 | |
| 0.046 | 0.039 | 0.046 | Prostaglandin E2 antagonist | |||
| 0.125 | 0.118 | 0.13 | Mcl-1 antagonist | 0.13 0.112 DBMET00887 | DBMET00887 | |
| 0.056 | 0.05 | 0.056 | Purinergic P2X1 antagonist | |||
| 0.047 | 0.041 | 0.047 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.033 | 0.027 | 0.033 | Retinoid X receptor agonist | |||
| 0.056 | 0.051 | 0.056 | Ryanodine receptor antagonist | |||
| 0.032 | 0.027 | 0.032 | Free fatty acid receptor 1 antagonist | |||
| 0.197 | 0.192 | 0.197 | Sodium/bile acid cotransporter inhibitor | |||
| 0.106 | 0.102 | 0.106 | NADPH oxidase inhibitor | |||
| 0.093 | 0.088 | 0.099 | Chelator | 0.099 0.078 DBMET00887 | DBMET00887 | |
| 0.028 | 0.024 | 0.028 | Phosphodiesterase 6B inhibitor | |||
| 0.12 | 0.116 | 0.12 | CC chemokine 6 receptor antagonist | |||
| 0.216 | 0.213 | 0.216 | DNA polymerase beta inhibitor | |||
| 0.013 | 0.01 | 0.013 | DNA polymerase III polC-type inhibitor | |||
| 0.053 | 0.052 | 0.057 | Leukotriene C antagonist | 0.057 0.037 DBMET00887 | DBMET00887 | |
| 0.041 | 0.041 | 0.046 | Glutamate (mGluR group I) agonist | 0.046 0.036 DBMET00887 | DBMET00887 | |
| 0.03 | 0.03 | 0.03 | Fumarate hydratase inhibitor | 0.03 0.029 DBMET00887 | DBMET00887 | |
| 0.065 | 0.067 | 0.09 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.09 0.043 DBMET00887 | DBMET00887 | |
| 0.065 | 0.069 | 0.078 | Glutamate receptor agonist | 0.078 0.055 DBMET00887 | DBMET00887 | |
| 0.05 | 0.057 | 0.053 | Adenine nucleotide translocase inhibitor | 0.053 0.046 DBMET00887 | DBMET00887 | |
| 0.034 | 0.048 | 0.037 | Leukotriene C4 antagonist | 0.037 0.035 DBMET00887 | DBMET00887 | |
| 0.073 | 0.089 | 0.082 | HIV-1 integrase (Overall Integration) inhibitor | 0.082 0.075 DBMET00887 | DBMET00887 | |
| 0.143 | 0.168 | 0.208 | Vasodilator | 0.208 0.099 DBMET00887 | DBMET00887 | |
| 0.027 | 0.066 | 0.053 | Adenosine deaminase inhibitor | 0.053 0.027 DBMET00887 | DBMET00887 | |
| 0.029 | 0.068 | 0.059 | Phosphodiesterase 4A inhibitor | 0.059 0.03 DBMET00887 | DBMET00887 | |
| 0.011 | 0.066 | 0.03 | Leukotriene D4 antagonist | 0.03 0.015 DBMET00887 | DBMET00887 | |
| 0.061 | 0.118 | 0.098 | Topoisomerase I inhibitor | 0.098 0.072 DBMET00887 | DBMET00887 | |
| 0.199 | 0.276 | 0.243 | Apoptosis agonist | 0.243 0.222 DBMET00887 | DBMET00887 | |
| 0.033 | 0.126 | 0.097 | Leukotriene synthesis inhibitor | 0.097 0.028 DBMET00887 | DBMET00887 | |
| 0.027 | 0.168 | 0.05 | Benzodiazepine inverse agonist | 0.05 0.025 DBMET00887 | DBMET00887 | |
| 0.035 | 0.193 | 0.072 | Phosphodiesterase 3A inhibitor | 0.072 0.068 DBMET00887 | DBMET00887 | |
| 0.163 | 0.336 | 0.268 | Cyclophilin D inhibitor | 0.268 0.193 DBMET00887 | DBMET00887 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |